ARCHIVES

Beth Israel Suspends Enrollment In Trials Following An Audit

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

41 CCOPs Reported For Recompetition

February 23, 1990

Letter In Response To Hadley; RFA Available

July 7, 1995

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994